Staying informed on key national and international developments is vital for candidates preparing for competitive examinations such as UPSC, MPSC, Banking, and SSC. Based on the weekly current affairs compiled by Majhi Naukri, the period between September 2, 2026, and September 5, 2026, featured several noteworthy announcements across international judiciary forums, defense manufacturing agreements, doctoral research funding, corporate leadership changes, medical approvals, and breakthroughs in life sciences. This roundup synthesizes these verified developments into an exam-oriented structure, attributing all reported facts directly to the source coverage while highlighting key details relevant for current affairs sections.
Judicial Diplomacy, Corporate Appointments, and Academic Fellowships
In judicial news, Majhi Naukri reported that the Supreme Court of India officially announced on September 3, 2026, that India would serve as host for the three-day BRICS Chief Justices’ Forum in New Delhi. The forum was scheduled to run from September 4, 2026, to September 6, 2026, taking place immediately prior to the 18th BRICS Summit. This event serves as an important judicial gathering aimed at strengthening legal dialogue and judicial coordination among BRICS member nations.
In corporate leadership updates reported by Majhi Naukri on September 3, 2026, San Jose-based software provider Adobe announced the appointment of Anil Chakravarthy as its upcoming president and chief executive officer (CEO). Chakravarthy, who currently heads Adobe’s Customer Experience Orchestration business unit, is set to join the company’s Board of Directors effective December 1, 2026. Candidates preparing for corporate and administrative awareness sections should note this executive transition.
Regarding educational initiatives, the All India Council for Technical Education (AICTE) launched the AICTE Innovation and Entrepreneurship Doctoral Fellowship Program (AIEDFP) on September 3, 2026. Majhi Naukri reported that this higher education scheme carries a total projected financial outlay of ₹245 crore over a five-year period. Under the program, funding and organizational support will be granted to 150 PhD fellowships dedicated specifically to research and development in the fields of innovation and entrepreneurship.
Defense Manufacturing Agreements and Indigenous Technology
The defense sector saw significant activity regarding domestic manufacturing and technology partnerships during this period. According to records published by Majhi Naukri, Drogo Aerospace Pvt Ltd and state-owned Munitions India Limited (MIL) executed a Memorandum of Understanding (MoU) in Pune on September 4, 2026. The MoU establishes a strategic framework for cooperation in indigenous unmanned aerial vehicles (UAVs) and loitering munition systems. The signed agreement covers multiple operational phases, including product design, development, system integration, safety evaluation, field trials, range trials, and quality certification of munition-linked aerial platforms.
In another major defense supply development, Adani Defence & Aerospace entered into a five-year commercial agreement with Indo-Russian Rifles Private Limited. As reported by Majhi Naukri, the contract pertains to the domestic supply of 7.62×39 mm small-calibre ammunition for the AK-203 assault rifle program. This arrangement ensures a continuous domestic supply of small-calibre ammunition for the Indian armed forces across the five-year duration, establishing a direct link between rifles produced locally in India and indigenous ammunition manufacturing.
Biomedical Approvals, Synthetic Biology, and Botanical Discoveries
In international healthcare and medical science, pharmaceutical manufacturer AstraZeneca announced on September 4, 2026, that the United States Food and Drug Administration (FDA) granted accelerated approval for Etcamah (camizestrant). Based on details provided by Majhi Naukri, the approval covers the treatment of adult patients diagnosed with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer featuring an ESR1 mutation. The approved therapeutic regimen specifies a daily oral dosage of 75 mg, administered in combination with CDK4/6 inhibitors such as abemaciclib, palbociclib, or ribociclib.
In biological research, researchers at the University of California San Diego demonstrated that RNA polymerase from Escherichia coli bacteria can successfully read and transcribe a synthetic eight-letter genetic alphabet. Majhi Naukri reported that the scientific study was led by Dong Wang at the Skaggs School of Pharmacy and Pharmaceutical Sciences and was published in the journal Nature Communications on September 2, 2026.
Additionally, in environmental and botanical news, a newly discovered species of flowering plant named Thismia daemona was formally described in the journal PhytoKeys on September 3, 2026. According to Majhi Naukri, the plant was initially discovered by a team of botanists during a 2025 field survey in Thailand’s western Thong Pha Phum National Park. Owing to its dark coloration and distinctive horned physical appearance, the plant earned the informal nickname “devil flower”.
Summary and Exam Significance
This weekly current affairs summary covering September 2 to September 5, 2026, highlights crucial developments across governance, defense self-reliance, academic fellowship programs, and scientific discovery. Aspirants should review these facts—attributed directly to Majhi Naukri's official tracking—for upcoming competitive examinations. While future outcomes such as board appointments taking effect in December 2026 remain subject to standard scheduled timelines, the institutional decisions made during this period provide essential reference points for current affairs preparation.
Majhi Naukri Original report